Care Following Nonfatal Overdose Among Medicare Beneficiaries – Study Identifies Interventions and Gaps

https://www.samhsa.gov/newsroom/press-announcements/20240617/federal-study-examines-care-following-nonfatal-overdose-among-medicare-beneficiaries?utm_source=SAMHSA&utm_campaign=96c6fddb8f-EMAIL_CAMPAIGN_2024_06_17_03_57&utm_medium=email&utm_term=0_-96c6fddb8f-%5BLIST_EMAIL_ID%5D&utm_source=SAMHSA&utm_campaign=f79b5a1f21-EMAIL_CAMPAIGN_2024_06_26_02_07&utm_medium=email&utm_term=0_-f79b5a1f21-%5BLIST_EMAIL_ID%5D Researchers from SAMHSA, the National Institutes of Health’s (NIH) National Institute on Drug Abuse (NIDA), Centers for Medicare & Medicaid Services (CMS), and the Centers for Disease Control and Prevention (CDC) found that among a cohort of 137,000 Medicare beneficiaries who experienced a nonfatal overdose in 2020, almost 24,000 (17.4%) experienced a subsequent nonfatal overdose, and about 1,300 (1%) died from overdose in the following year. Results were published recently in JAMA Internal Medicine, identifying both effective interventions and significant gaps in care.